In“

 
   

  
  

 
 
 

_‘__‘___ _ w». v w \M ‘. ‘_ Viawﬁ‘s'ﬁ ~. 1" A: «q . Him ”H‘PL. 12/33
._ Q 7 >_ — — — H
AGNOSIS: va ,
81W. 5 l. ‘ ¢ 1 S . J -' ,. V" - ‘l
A NVAQI-VE {6513133}: ngN%M-A,,’15 . RING FEATURES, NOITINCHAM SCORE 6 /9,

 
  

(ruiluu. -.. . i .
TUMOR 15 CE
LYMPH‘ ‘

  
   

 

PART' I _ - - 4. 3y , ,.

PARTS: momma Wall 3 ., .
ONE LYMBH NODE-ISECAIIV-EJOK

 

PART 4; mam AXILLA, SliINTINEL “MP“ "ODE “'

'5‘; ' I" ' '-
om: WW“ Nam; NEGATIVE FOR TUMOR. . u .. an,“ , , N
CASE SYNOPSIS: " "

SYNOPTIC - PRIMARY INVASIVE CARCINOMA OFBREAST'
TY- '

 

PROCEDURE: Simple mastectomy
LOCATION: _ Central subareolar
SIZE OF TUMOR: ‘ Maximum dimension invaslve component: 5.5 cm
MULTICENTRICITY/MULTIFOCALITY OFVINVAISIVE FOCI:

' _ No
TUMOR TYPE (invasive component): , lob _ g , 3

lnﬁlltating lobular carcinoma \ v é g. H £5016

HISTOLOGIC TYPE: ‘CIasSIcoI. Signet ring 4mm, WI 7 /’ “W /3
NOTTINGHAM SCORE: Nuclear grade: 2 5%: W [015 c 50, ‘2’ 3/0/11 ,4,

Tubule formation: 3

Mltotic activity, score: 1

Total Nottingham score: 6
Nottingham grade (1, 2. 3); 2
No

 

ANGIOLYMPHATIC INVASION: .
DERMAL LYMPHATIC INVASION: No
CALCIFICATION: Yes. benign zones

Yes, malignant zones
TUMOR TYPE. IN SITU: LCIS

Percent of tumor occupied by in situ component: 2 °/o
SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:

No
SURG MARGINS INVOLVED BY IN SITU COMPONENT: ’ ‘

_ , _ _4AA1-572c-3993E7863235
PAGET‘S DISEASE OF NIPPLE: It}: uum.§'%1§§3:-5A1§gp'°1A-PR I|||||i‘.||e||‘iﬁ|c|||ted
LY“°“~°°ES°°S"'VE= ° Ill||llllllllllllllIIlllll|||Illllllllllllllllllll "I“
”W” ””53 ”WED“ 4 III lIllllllllllllllllllllIIllllllllllllllllllllllllllllllll
”ET”°°‘3’ 0" ”MP“ "°°E EW'"”'°"= Illllllllllllllllllllllllllllllllllllllll
, HEWmsmm Illllllllllllllll
" """'”“‘ '“SENTINEL NODE METASTASIS: Yes
ONLY KERATIN POSITIVE CELLS ARE PRESENT:
Yes
SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis; 0.15 mm
LYMPH NODE METASTASISI—ES) WITH EXTRACAPSULAR EXTENSION:
O

SKIN INVOLVED IULCERATION): No
NON-NEOPLASTIC BREAST TISSUE: FCD, Other: SCIerosmg adenosis.

T STAGE. PATHOLOGIC: pT3
Ni STAGE. PATHOLOGIC: pNO(i-)
M STAGE, PATHOLOGIC: DMX
ESTROGEN RECEPTORS: positive

 
     

PROGESTERONE RECEPTORS: positive
EU: zero or 1+

     

